FDA Compliance

Understanding Pharmaceutical Recalls, Key Players, and Their Roles

by Veronica Salib

Like any industry, recalls in the pharmaceutical industry are complex and expensive. However, as an added concern, pharmaceutical recalls have the potential to alter short and long-term health outcomes. Understanding the recall process for...

Understanding FDA Advisory Committees, Aims, and Members

by Veronica Salib

The United States Food and Drug Administration (FDA) approval process is complex and involves multiple people's input, opinions, and expertise, including the FDA advisory committees. Every time a new drug is approved, a recall is...

Understanding the FDA’s Expedited Approval Pathways

by Veronica Salib

The United States Food and Drug Administration (FDA) is responsible for regulating everything from cosmetic products to medical devices to prescription drugs. In recent years, the FDA has been under enormous pressure to accelerate its...

How A Prescription Drug Becomes Available Over the Counter

by Veronica Salib

The FDA approval process is complex and involves multiple steps. Understanding how a prescription drug becomes available over the counter (OTC) is essential for healthcare professionals, members of the pharmaceutical industry, and...

US FDA Accelerated Approval for 48 Non-oncology Drugs

by Veronica Salib

The FDA approval process is multi-faceted and involves several aspects. One of these aspects is accelerated approval, which is meant to approve drugs to treat severe or fatal diseases. According to a...

FDA Issues Guidance for Dietary Supplement Marketplace

by Hayden Schmidt

The FDA announced guidance Thursday that allows manufacturers and distributors of dietary supplements to submit late new dietary ingredient (NDI) notifications if they have failed to do so. Directors...

Pharma Company Earns $311M for Cannabinoid Medicines

by Samantha McGrail

GW Pharmaceuticals announced last week that its cannabinoid (CBD) prescription medicines brought in total revenue of $109.1 million for the fourth quarter of 2019, and $311.3 million for the full...

Esperion Earns FDA Approval for Cholesterol Lowering Drug Nexletol

by Samantha McGrail

Esperion recently announced that the FDA approved Nexletol an LDL-cholesterol lowering medicine, boosting access to medicine for patients with familial hypercholesterolemia or atherosclerotic...

FDA Proposes Policies for Pediatric Studies

by Ana Mulero

Study sponsors will be subject to a new requirement for pediatric investigations beginning August 18, with new Food and Drug Administration draft guidance offering transitional information.  The...

Study: FDA Should Simplify Drug Approval Programs

by Ana Mulero

A new study published Tuesday in JAMA suggests that the evolution of drugs and biologics’ regulatory approval programs at the US Food and Drug Administration has resulted in a system that...